Why is Dr Reddy's Labs falling/rising?

As of 05-Jun, Dr Reddys Laboratories Ltd is experiencing a price increase, currently at 1,289.90, reflecting a rise of 37.9 (3.03%). The stock has outperformed its sector by 1.97% today and has shown consecutive gains over the last two days, accumulating a total return of 3.31% in this period. Additionally, the stock has reached an intraday high of Rs 1303.45, indicating strong upward momentum. Despite a decline in delivery volume by 19.51% against the 5-day average, the stock remains technically bullish, trading above all key moving averages. The company’s fundamentals are robust, characterized by low debt, strong long-term growth, and high profitability, which contribute positively to its recent performance.
In the broader market context, Dr Reddy's Laboratories has outperformed the Sensex over the past week, with a return of +3.35% compared to the benchmark's -0.23%. While the stock has shown a year-to-date decline of -7.08%, it has outperformed the Sensex in the past month with a return of +10.01% against the benchmark's +0.80%. The high institutional holdings at 62.91% suggest confidence from larger investors, which may further support the stock's upward trajectory. However, the company faces risks due to flat results in the previous quarter and a decline in profit before tax, which could impact future performance if not addressed.